Clinical impact of the baseline echocardiogram in children with high-risk acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 57, Issue 2, 2011, Pages 227-230

  Avelar, Taurino ^a   Pauliks, Linda B ^a   Freiberg, Andrew S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Anthracycline; Chemotherapy; Child; Echocardiography; Leukemia

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; ASPARAGINASE MACROGOL; DAUNORUBICIN; DEXAMETHASONE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AORTA VALVE REGURGITATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; INFANT; MALE; MITRAL VALVE REGURGITATION; PERICARDIAL EFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT CONTRAINDICATION; TREATMENT PLANNING;

ADOLESCENT; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; DRUG TOXICITY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79958830287     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23066     Document Type: Article

References (15)

1. Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266: 1672-1677.
2. Carroll JB, Hunger SP, Borowitz MJ, et al. Risk-adapted therapy for children with acute lymphoblastic leukemia (ALL): The Children's Oncology Group (COG) approach. Ann Hematol 2008; 87: S42-S44.
3. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900-905.
4. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin (Adriamycin) therapy for childhood acute lymphoblastic leukemia. N Engl J Med 1991; 324: 808-915.
5. Kremer LC, Caron HN. Anthracycline cardiotoxicity in children. N Engl J Med 2004; 351: 120-121.
6. Steinherz LJ, Graham T, Hurwitz R, et al. Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Children's Cancer Study Group. Pediatrics 1992; 89: 942-949.
7. Kapusta L, Groot-Loonen J, Thijssen JM, et al. Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy. Med Pediatr Oncol 2003; 41: 426-435.
8. Kampmann C, Wiethoff C, Wenzel A, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000; 83: 667-672.
9. Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: Prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985; 121: 31-36.
10. George RE, Lipshultz SE, Lipsitz SR, et al. Association between congenital cardiovascular malformations and neuroblastoma. Pediatrics 2004; 144: 444-448.
11. Di Tullio MR. Patent foramen ovale: Echocardiographic detection and clinical relevance in stroke. J Am Soc Echocardiogr 2010; 23: 144-155.
12. Bierman HR, Perkins EK, Ortega P. Pericarditis in patients with leukemia. Am Heart J 1952; 43: 413-422.
13. Sampat K, Rossi A, Garcia-Gutierrez V, et al. Characteristics of pericardial effusions in patients with leukemia. Cancer 2010; 116: 2366-2371.
14. Porea TJ, Dreyer ZE, Bricker JT, et al. Evaluation of left ventricular function in asymptomatic children about to undergo anthracycline-based chemotherapy for acute leukemia: An outcome study. J Ped Heme/Onc 2001; 23: 420-423.
15. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003; 348: 1647-1655.